Literature DB >> 17516163

Protection of the abnormal heart.

Constantinos Pantos1, Iordanis Mourouzis, Dennis V Cokkinos.   

Abstract

Myocardial ischemia and reperfusion injury have been extensively investigated in the laboratory mainly in healthy tissues. However, in clinical settings, ischemic heart disease coexists with certain illnesses, which could potentially influence the response of the myocardium to ischemia and reperfusion. Recent research has revealed that the abnormal heart may not be always vulnerable to ischemic injury. Furthermore, the effect of powerful means of protection, such as ischemic preconditioning, may not be in operation under certain pathological conditions. With this evidence in mind, the present review will focus on the response of the abnormal heart to ischemia and reperfusion, the possible underlying mechanisms, and potential cardioprotective strategies.

Entities:  

Mesh：

Year:  2007        PMID： 17516163     DOI： 10.1007/s10741-007-9036-z

Source DB:  PubMed          Journal:  Heart Fail Rev        ISSN： 1382-4147            Impact factor:   4.214


  127 in total

1.  Effect of aging on the ability of preconditioning to protect rat hearts from ischemia-reperfusion injury.

Authors:  D Schulman; D S Latchman; D M Yellon
Journal:  Am J Physiol Heart Circ Physiol       Date:  2001-10       Impact factor: 4.733

2.  Thyroid hormone receptors alpha1 and beta1 are downregulated in the post-infarcted rat heart: consequences on the response to ischaemia-reperfusion.

Authors:  C Pantos; I Mourouzis; T Saranteas; I Paizis; C Xinaris; V Malliopoulou; D V Cokkinos
Journal:  Basic Res Cardiol       Date:  2005-09       Impact factor: 17.165

3.  Effects of insulin resistance on geranylgeranylacetone-induced expression of heat shock protein 72 and cardioprotection in high-fat diet rats.

Authors:  Tatsuhiko Ooie; Munetaka Kajimoto; Naohiko Takahashi; Tetsuji Shinohara; Yayoi Taniguchi; Hiroaki Kouno; Osamu Wakisaka; Hironobu Yoshimatsu; Tetsunori Saikawa
Journal:  Life Sci       Date:  2005-07-08       Impact factor: 5.037

4.  No loss in the in vivo efficacy of ischemic preconditioning in middle-aged and old rabbits.

Authors:  K Przyklenk; G Li; P Whittaker
Journal:  J Am Coll Cardiol       Date:  2001-11-15       Impact factor: 24.094

5.  Ischaemic preconditioning does not protect the heart in obese and lean animal models of type 2 diabetes.

Authors:  S B Kristiansen; B Løfgren; N B Støttrup; D Khatir; J E Nielsen-Kudsk; T T Nielsen; H E Bøtker; A Flyvbjerg
Journal:  Diabetologia       Date:  2004-10-07       Impact factor: 10.122

6.  Cardioprotection with cariporide, a sodium-proton exchanger inhibitor, after prolonged ischemia and reperfusion in senescent rats.

Authors:  Sophie Besse; Stéphane Tanguy; François Boucher; Christine Le Page; Sandrine Rozenberg; Bruno Riou; Joël de Leiris; Bernard Swynghedauw
Journal:  Exp Gerontol       Date:  2004-09       Impact factor: 4.032

7.  Contradictory effects of short- and long-term hyperglycemias on ischemic injury of myocardium via intracellular signaling pathway.

Authors:  Guang Xu; En Takashi; Mitsuhiro Kudo; Toshiyuki Ishiwata; Zenya Naito
Journal:  Exp Mol Pathol       Date:  2004-02       Impact factor: 3.362

8.  Hypercholesterolemia blunts NO donor-induced late preconditioning against myocardial infarction in conscious rabbits.

Authors:  Xian-Liang Tang; Adam B Stein; Gregg Shirk; Roberto Bolli
Journal:  Basic Res Cardiol       Date:  2004-09-16       Impact factor: 17.165

9.  Captopril cardioplegia on myocardial protection in the hypertrophied rat hearts.

Authors:  Y H Zhang; S C Xu
Journal:  Int J Cardiol       Date:  1994-12       Impact factor: 4.164

10.  Effects of regression of left ventricular hypertrophy following atenolol or bunazosin therapy on ischemic cardiac function and myocardial metabolism in spontaneously hypertensive rats.

Authors:  H Tanaka; H Obata; T Haneda
Journal:  Jpn Circ J       Date:  1991-12
View more
  4 in total

1.  Thyroid hormone can favorably remodel the diabetic myocardium after acute myocardial infarction.

Authors:  Christos Kalofoutis; Iordanis Mourouzis; Georgios Galanopoulos; Antonios Dimopoulos; Philippos Perimenis; Danai Spanou; Dennis V Cokkinos; Jaipaul Singh; Constantinos Pantos
Journal:  Mol Cell Biochem       Date:  2010-08-22       Impact factor: 3.396

Review 2.  New insights into the role of thyroid hormone in cardiac remodeling: time to reconsider?

Authors:  Constantinos Pantos; Iordanis Mourouzis; Dennis V Cokkinos
Journal:  Heart Fail Rev       Date:  2011-01       Impact factor: 4.214

3.  Propofol improves recovery of the isolated working hypertrophic heart from ischaemia-reperfusion.

Authors:  Nicola King; Madj Al Shaama; M-Saadeh Suleiman
Journal:  Pflugers Arch       Date:  2012-09-22       Impact factor: 3.657

4.  Effects of ischemic preconditioning on ischemia/reperfusion-induced arrhythmias by upregulatation of connexin 43 expression.

Authors:  Zhenguang Chen; Honghe Luo; Mei Zhuang; Lie Cai; Chunhua Su; Yiyan Lei; Jianyong Zou
Journal:  J Cardiothorac Surg       Date:  2011-06-02       Impact factor: 1.637
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.